Aimed Alliance Hosts Discussion on Step Therapy Reform in New York
On October 17, 2022, the New York Step Therapy Alliance hosted a roundtable meeting to discuss the current state of…
Browsing: Step Therapy: Resources
New York Legislature Passes Legislation with Important Patient Protections During the 2022 Session
Press Release – July 6, 2022 (Albany, New York) – Over thirty patient advocacy and health policy organizations applaud the…
Aimed Alliance Releases Know Your Rights Resource For Patients With Cardiovascular Diseases
On February 10, 2022, Aimed Alliance released a new Know Your Rights brochure for patients living with cardiovascular disease. The…
Step Therapy Reform: Categorical Exceptions
In 2022, Senator Breslin introduced S8193 and Assemblyman McDonald introduced A9250 which would prohibit the use of step therapy policies in…
Step Therapy Reform: Increased Reporting and Transparency
In 2022, Senator Breslin introduced S8194 and S8798 and Assemblyman McDonald introduced A9265 and A9206 and Requiring insurers and utilization…
Step Therapy Reform: Clinical Peer Review of Step Therapy Decision Making
In 2022, the New York Legislature passed S8113 and A879 which requires a clinical peer-reviewer to be a licensed health…
Step Therapy Reform: Strengthening Enforcement and Patient Protections to Deter Step Therapy Violations
In 2022, Senator Breslin introduced S8191, and Assemblyman McDonald introduced A9267 to create additional step-therapy patient protections, such as prohibiting…
Step Therapy Reform: Dermatological Conditions
Requiring patients with dermatological conditions to try and fail alternative treatments before the insurer or pharmacy benefit manager will cover…
Step Therapy Reform: Gastroenterological Conditions
Mandating patients with gastroenterological conditions undergo step therapy before the prescribed treatment is covered may result in significant discomfort, hospitalization,…
Step Therapy Reform: Hematological Conditions
Requiring patients to “fail first” on alternative treatments can be particularly harmful and burdensome for patients with hematological conditions, who…